EXCELIMMUNE INC has a total of 12 patent applications. Its first patent ever was published in 2011. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are COMPOUND THERAPEUTICS INC, APROGEN INC and RECOPHARMA AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Coljee Vincent W | 11 |
#2 | Shulga-Morskoy Sergey | 1 |
#3 | Wilmes Gwen | 1 |
#4 | Coljee Vincent | 1 |
#5 | Russell Hugh | 1 |
Publication | Filing date | Title |
---|---|---|
WO2014160098A2 | Bordetella specific human recombinant antibodies and uses thereof | |
WO2014121031A1 | Characterization of antibody mixtures by mass spectrometry | |
AU2011329872A1 | Methods for producing recombinant proteins | |
AU2011295702A1 | Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof |